$25.30
0.732.99%
Last update: Nov 4, 2:52 PM
Elanco Animal Health Inc
ELANNYSE
Elanco Animal Health (ELAN) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Elanco Animal Health (ELAN) last issued guidance on August 5, 2026 for Q3 2026. The company guided earnings per share in the range of $0.19 - $0.22, compared to a consensus EPS estimate of $0.19. Elanco Animal Health also guided revenue in the range of $1.2B - $1.22B for the period.
Compared to prior guidance, Elanco Animal Health lowered its revenue forecast from a prior range of $5.09B - $5.14B.
Elanco Animal Health has issued 34 guidance updates between November 8, 2022 and August 5, 2026. During this period, the company raised its outlook 12 times and lowered it 15 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.27 | $0.34 | $0.11 | $0.13 |
| Actual | $0.34 | $0.40 | $0.13 | $0.19 |
| Surprise | +25.9% | +17.6% | +18.2% | +46.2% |
| Revenue | ||||
| Estimate | $1.31B | $1.28B | $1.09B | $1.09B |
| Actual | $1.37B | $1.37B | $1.14B | $1.14B |
| Surprise | +4.26% | +7.40% | +4.72% | +4.15% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.20 | $0.18 | $0.44 | $0.36 |
| Revenue | ||||
| Consensus | $1.21B | $1.19B | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 5, 2026 | $0.34 | $0.27 | 25.9 % |
| Q1 | May 6, 2026 | $0.40 | $0.34 | 17.6 % |
| Q4 | Feb 24, 2026 | $0.13 | $0.11 | 18.2 % |
| Q3 | Nov 5, 2025 | $0.19 | $0.13 | 46.2 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 5, 2026 | $1.37B | $1.31B | 4.26 % |
| Q1 | May 6, 2026 | $1.37B | $1.28B | 7.40 % |
| Q4 | Feb 24, 2026 | $1.14B | $1.09B | 4.72 % |
| Q3 | Nov 5, 2025 | $1.14B | $1.09B | 4.15 % |
